AZD1305
Sponsors
AstraZeneca
Conditions
Atrial FibrillationAtrial FlutterHealthyLeft Ventricle Function
Phase 1
Study of an Extended Release (ER) Tablet, Single and Repeated Dosing
CompletedNCT00689039
Start: 2007-04-30End: 2008-07-31Updated: 2010-12-03
Single Ascending Dose Study (SAD) iv Formulation
CompletedNCT00688831
Start: 2008-01-31End: 2008-05-31Updated: 2010-12-02
To Study the Absorption, Distribution, Metabolism and Excretion of AZD1305
CompletedNCT00689247
Start: 2008-04-30End: 2008-05-31Updated: 2010-12-03
Evaluate Different Extended-release (ER) Tablets/Capsules of AZD1305
CompletedNCT00689403
Start: 2008-02-29End: 2008-07-31Target: 50Updated: 2010-12-03
An Interaction Study of Ketoconazole/Verapamil Versus AZD1305
CompletedNCT00707551
Start: 2008-07-31End: 2008-11-30Target: 27Updated: 2010-12-03
An Interaction Study With Digoxin and AZD1305
CompletedNCT00712465
Start: 2008-08-31End: 2008-11-30Updated: 2010-12-03
To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese Subjects
CompletedNCT00738322
Start: 2008-07-31End: 2008-10-31Target: 36Updated: 2009-06-30
AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects
TerminatedNCT00935025
Start: 2009-07-31End: 2009-11-30Target: 45Updated: 2010-12-07
Study to Assess Drug Concentrations in Plasma of Different Extended-release Formulations of AZD1305
CompletedNCT00957437
Start: 2009-08-31End: 2009-11-30Target: 24Updated: 2009-11-26
Phase 2
Cardiac Electrophysiological Study
CompletedNCT00616629
Start: 2008-01-31End: 2008-06-30Updated: 2011-09-22
Explorative Study of AZD1305 in Atrial Fibrillation Patients
CompletedNCT00643448
Start: 2008-03-31End: 2008-08-31Updated: 2012-01-26
Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction
CompletedNCT00748982
Start: 2008-08-31End: 2009-07-31Updated: 2011-06-27
Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305
CompletedNCT00915356
Start: 2009-05-31End: 2009-12-31Updated: 2012-02-01